Matches in Wikidata for { <http://www.wikidata.org/entity/Q64715670> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q64715670 description "clinical trial" @default.
- Q64715670 description "ensayu clínicu" @default.
- Q64715670 description "klinisch onderzoek" @default.
- Q64715670 description "клінічне випробування" @default.
- Q64715670 description "կլինիկական փորձարկում" @default.
- Q64715670 name "A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy" @default.
- Q64715670 type Item @default.
- Q64715670 label "A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy" @default.
- Q64715670 prefLabel "A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy" @default.
- Q64715670 P1132 Q64715670-135F1A4C-9FA3-4208-B4A4-7021E5C4F401 @default.
- Q64715670 P1476 Q64715670-6E8B2D11-7B72-47A8-B08C-EA992771B87F @default.
- Q64715670 P17 Q64715670-085D4D77-EF25-4111-AD5E-D53AC092F01C @default.
- Q64715670 P17 Q64715670-0FD5D812-0C51-4BE9-90A4-8F9541A5F5F4 @default.
- Q64715670 P17 Q64715670-267300ED-776D-48F2-9286-D38EA1112A46 @default.
- Q64715670 P17 Q64715670-50928976-4B05-471D-AFAE-F82FACDDD5D8 @default.
- Q64715670 P17 Q64715670-61D364FF-DD16-481C-83CD-DF58C3290ACF @default.
- Q64715670 P17 Q64715670-7B4B94DA-A267-44DF-A183-0A33E9E25137 @default.
- Q64715670 P17 Q64715670-7EFA2EC9-BF00-4222-9316-76DC90E13716 @default.
- Q64715670 P17 Q64715670-A59992F4-674C-4935-818E-65FBBE54B3CA @default.
- Q64715670 P17 Q64715670-B4B43ADD-E632-4728-9971-C7A83FA24FCF @default.
- Q64715670 P17 Q64715670-C9DF6AC9-6B04-48CE-AB7B-310A86614475 @default.
- Q64715670 P17 Q64715670-DF4B4732-9C33-4A30-B9B9-17008D1BC583 @default.
- Q64715670 P17 Q64715670-F2199DA8-C0C7-4B1E-89D0-185B1D4563CA @default.
- Q64715670 P2899 Q64715670-97692076-FD45-4DB3-A53F-D573166EAA88 @default.
- Q64715670 P3098 Q64715670-F491A049-3D9A-4124-A92F-C69EE37CB66F @default.
- Q64715670 P31 Q64715670-5503D283-F6C1-47BD-B4D0-A969A15C186D @default.
- Q64715670 P580 Q64715670-0CC1C321-7000-462F-AF83-064447D13CC5 @default.
- Q64715670 P582 Q64715670-7BB8F22D-4F25-478F-9D1D-E7352B108BF0 @default.
- Q64715670 P6099 Q64715670-9DDEA361-D88E-472A-9044-C86BB5A8139D @default.
- Q64715670 P8363 Q64715670-B1CF34E4-6CEA-499B-9CFE-CA7ED3456F6A @default.
- Q64715670 P1132 "+526" @default.
- Q64715670 P1476 "A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Ustekinumab Therapy in Subjects With Moderately to Severely Active Crohn's Disease Previously Treated With TNF Antagonist Therapy" @default.
- Q64715670 P17 Q142 @default.
- Q64715670 P17 Q145 @default.
- Q64715670 P17 Q16 @default.
- Q64715670 P17 Q183 @default.
- Q64715670 P17 Q29 @default.
- Q64715670 P17 Q30 @default.
- Q64715670 P17 Q31 @default.
- Q64715670 P17 Q40 @default.
- Q64715670 P17 Q408 @default.
- Q64715670 P17 Q55 @default.
- Q64715670 P17 Q664 @default.
- Q64715670 P17 Q801 @default.
- Q64715670 P2899 "+18" @default.
- Q64715670 P3098 "NCT00771667" @default.
- Q64715670 P31 Q30612 @default.
- Q64715670 P580 "2008-12-01T00:00:00Z" @default.
- Q64715670 P582 "2010-05-01T00:00:00Z" @default.
- Q64715670 P6099 Q42824440 @default.
- Q64715670 P8363 Q78089383 @default.